CLGN — Collplant Biotechnologies Cashflow Statement
0.000.00%
Last trade - 00:00
- $67.47m
- $40.79m
- $10.96m
- 53
- 22
- 76
- 49
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -11.2 | -5.77 | 0.237 | -16.9 | -7.02 |
Depreciation | |||||
Non-Cash Items | 4.67 | 1.79 | 1.27 | 2.69 | 2.33 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.247 | -1.12 | 0.216 | -0.544 | 0.82 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -5.7 | -4.45 | 2.5 | -13.7 | -2.76 |
Capital Expenditures | -1.49 | -0.519 | -1.59 | -1.32 | -0.954 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.03 | 0 | -30 | 30.2 | -0.202 |
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1.46 | -0.519 | -31.6 | 28.9 | -1.16 |
Financing Cash Flow Items | -0.017 | — | 0 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 5.41 | 4.46 | 38.8 | 1.87 | 1.11 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.69 | -0.445 | 9.85 | 16.5 | -3.19 |